CLINICAL_TRIALS
trial_result
· 2020-03-13
Clinical Trial Update: Safety of 1 g and 2 g of Cefazolin in Pediatric Subjects [Phase 4]
Summary
Phase 4 trial update evaluating safety of 1 g and 2 g cefazolin in pediatric subjects with postoperative infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: B. Braun Medical Inc. | Conditions: Postoperative Infection | Phase 4 | Status: TERMINATED | Results posted: 2020-03-13